Evidence map›Paper›PMID 33102601›Full record

ArticleBioMed research international2020

Anticolorectal Cancer Effects of AUCAN: Effects to Suppress Proliferation, Metastasis, and Invasion of Tumor Cells.

Liu-Lin Xiong, Ruo-Lan Du, Jun-Jie Chen, Ya Jiang, Lu-Lu Xue, Rui-Ze Niu, Li Chen, Jia Liu, Ting-Hua Wang

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Liu-Lin XiongInstitute of Neurological Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.ORCID https://orcid.org/0000-0002-1623-5969
Ruo-Lan DuInstitute of Neurological Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
Jun-Jie ChenDepartment of Anesthesiology, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, Sichuan, China.
Ya JiangInstitute of Neuroscience, Animal Zoology Department, Kunming Medical University, Kunming 650031, Yunnan, China.
Lu-Lu XueInstitute of Neuroscience, Animal Zoology Department, Kunming Medical University, Kunming 650031, Yunnan, China.
Rui-Ze NiuInstitute of Neuroscience, Animal Zoology Department, Kunming Medical University, Kunming 650031, Yunnan, China.
Li ChenInstitute of Neurological Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
Jia LiuInstitute of Neuroscience, Animal Zoology Department, Kunming Medical University, Kunming 650031, Yunnan, China.ORCID https://orcid.org/0000-0001-5678-7437
Ting-Hua WangInstitute of Neurological Disease, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.ORCID https://orcid.org/0000-0003-2012-8936
Kunming Medical University · CNSichuan University · CNSouthwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is an underlying deadly malignancy with poor prognosis, lacking effective therapies currently available to improve the prognosis. C

methodsCell Counting Kit-8 assay and immunofluorescence staining were used to investigate the effect of AUCAN on the viability and proliferation of HCT-116 cells and RKO cells. The apoptosis of HCT-116 and RKO cells after AUCAN administration was determined by the flow cytometry test. The effects of AUCAN on invasion and migration of tumor cells were investigated by the colony formation assay, wound healing test, and Transwell invasion test. Meanwhile, the energy metabolism and growth of tumor tissues after AUCAN administration with 10 mg/kg and 20 mg/kg were examined by PET-CT

resultsThe results showed that AUCAN suppressed the migratory abilities and enhanced apoptosis of HCT-116 and RKO cell lines. Meanwhile, AUCAN treatment dramatically depressed the growth and volume of colorectal tumors in nude mice and suppressed the survival of RKO cells in tumor tissues without any side effects on the blood routine and liver function. In addition, twenty-four upregulated and forty-two downregulated proteins were identified. Additionally, functional clustering analysis concealed enriched biological processes, cellular components, molecular functions, and related pathways of these proteins involved in cellular metabolic. Finally, the protein-protein interaction analysis revealed the regulatory connection among these DEPs.

conclusionsTaken together, AUCAN exerted its significant antitumor effect without side effects in the blood routine and liver function and the underlying mechanisms were preliminarily investigated by proteomic analysis.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisCell Line, TumorCell MovementCell ProliferationColorectal NeoplasmsDibenzofuransDrugs, Chinese HerbalFemaleHCT116 CellsHumansMiceMice, NudeNeoplasm InvasivenessNeoplasm MetastasisAntineoplastic Agents, PhytogenicDibenzofuransDrugs, Chinese Herbal

Identifiers

PMID33102601
PMCPMC7569457
OpenAlexW3092108449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.